Zoetis (ZTS) EBITDA (2012 - 2026)

Zoetis (ZTS) has 15 years of EBITDA data on file, last reported at $833.0 million in Q1 2026.

• EBITDA for Q1 2026 came in at $833.0 million, down 1.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 billion (up 4.36% YoY), and the FY2025 annual result was $3.7 billion, up 5.33% from the prior year.
• EBITDA fell to $833.0 million in Q1 2026 per ZTS's latest filing, from $841.0 million in the prior quarter.
• Over five years, EBITDA peaked at $1.0 billion in Q2 2025 and troughed at $728.0 million in Q4 2022.
• A 5-year average of $837.5 million and a median of $828.0 million in 2022 frame the typical range for EBITDA.
• The sharpest annual moves came in 2022 and 2023: EBITDA surged 736.92% in 2022, then retreated 10.14% in 2023.
• A 5-year view of EBITDA shows it stood at $728.0 million in 2022, then climbed by 2.34% to $745.0 million in 2023, then advanced by 7.65% to $802.0 million in 2024, then rose by 4.86% to $841.0 million in 2025, then dropped by 0.95% to $833.0 million in 2026.
• Business Quant data shows ZTS's EBITDA at $833.0 million in Q1 2026, $841.0 million in Q4 2025, and $964.0 million in Q3 2025.